CTAD Notebook: Novo Explains Semaglutide Alzheimer’s Rationale, Roche’s Trontinemab Update

 
• By Mandy Jackson
  
Semaglutide did not work in Alzheimer's disease, but trontinemab reduces amyloid plaques (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Scrip